Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Undecanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetostearyl Alcohol SCHEMBL28668273 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Cetyl Alcohol SCHEMBL9782972 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Decanol SCHEMBL28463807 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| 1-Hexanol SCHEMBL8015503 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Cetyl Alcohol SCHEMBL1360724 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Docosanol SCHEMBL6307010 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Octanol SCHEMBL208036 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Myristyl Alcohol SCHEMBL4612309 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Sulfuric Acid SCHEMBL5510760 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Sulfuric Acid SCHEMBL9563634 | 1.00 | LMNA (0.72) | LMNAALDH1A1TSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118754570-B | Multifunctional repair mortar and preparation method thereof | 山东铁壁虎建材有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-118754570-A | Multifunctional repair mortar and preparation method thereof | 山东铁壁虎建材有限公司 | 2024-10-11 | — | — | CN | disclosed |
| US-11560530-B2 | Surfactants based on monounsaturated fatty alcohol derivatives | STEPAN COMPANY (US) | 2023-01-24 | — | — | US | disclosed |
| EP-2967033-B1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | STEPAN CO (US) | 2019-10-02 | — | — | EP | disclosed |
| US-20190225915-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | STEPAN COMPANY | 2019-07-25 | — | — | US | disclosed |
| US-10287530-B2 | Surfactants based on monounsaturated fatty alcohol derivatives | STEPAN COMPANY (US) | 2019-05-14 | — | — | US | disclosed |
| US-20170267946-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | STEPAN CO (US) | 2017-09-21 | — | — | US | disclosed |
| US-9695385-B2 | Surfactants based on monounsaturated fatty alcohol derivatives | STEPAN COMPANY (US) | 2017-07-04 | — | — | US | disclosed |
| EP-2967033-A2 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | Stepan Company (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20160002571-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | STEPAN CO (US) | 2016-01-07 | — | — | US | disclosed |
| WO-2014164156-A2 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | STEPAN COMPANY (US) | 2014-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11560530-B2 | Surfactants based on monounsaturated fatty alcohol derivatives | ELOVL1, SCD, ELOVL3 | LMNA 925/4885ALDH1A1 1527/4885TSHR 2011/4885 |
| US-20170267946-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | ELOVL1, SCD, ELOVL3 | LMNA 925/4885ALDH1A1 1527/4885TSHR 2011/4885 |
| US-20160002571-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | ELOVL1, SCD, ELOVL3 | LMNA 925/4885ALDH1A1 1527/4885TSHR 2011/4885 |
| US-10287530-B2 | Surfactants based on monounsaturated fatty alcohol derivatives | ELOVL1, SCD, ELOVL3 | LMNA 925/4885ALDH1A1 1527/4885TSHR 2011/4885 |
| US-20190225915-A1 | SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES | ELOVL1, SCD, ELOVL3 | LMNA 925/4885ALDH1A1 1527/4885TSHR 2011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.